Anan zaka iya samun jerin Manyan Jamusanci Kamfanonin Magunguna wanda aka jera bisa ga jimlar tallace-tallace a cikin 'yan shekarun nan. Bayer ita ce mafi girma Kamfanin Pharma a Jamus tare da jimlar tallace-tallace na dala biliyan 51 a cikin shekarar da ta gabata.
Jerin Manyan Kamfanonin Magunguna na Jamus
Don haka ga Jerin Manyan Jamusawa Kamfanonin Magunguna wanda aka jera bisa ga jimlar tallace-tallace (Revenue).
1. Bayer AG girma
Bayer ita ce Jamus mafi girma Kamfanin Magunguna bisa ga kudaden shiga. Kamfanin yana mai da hankali kan bincike, haɓakawa da tallata sabbin magunguna na musamman waɗanda ke ba da fa'ida da ƙima na asibiti, musamman a fannonin warkewa na cututtukan zuciya, cututtukan cututtukan zuciya, ilimin mata, ilimin jini da kuma ophthalmology.
- Kudin shiga: $51 Billion
- ROE: 1%
- Bashi/Adalci: 1.3
- ma'aikataku: 100k
Babban cibiyoyin bincike na Kamfanin Bayer suna cikin Berlin, Wuppertal da Cologne, Jamus; San Francisco da Berkeley, Amurka; Turku, Finland; da Oslo, Norway.
2. Merck KGaA
Merch shine kamfani na 2 mafi girma na Kamfanin Magunguna na Jamus dangane da jimlar tallace-tallace (Kudi). Kamfanin ya gano, haɓakawa, kerawa, da kuma tallata sabbin magunguna da magungunan ƙwayoyin cuta don magance cutar kansa, sclerosis da yawa (MS), rashin haihuwa, cututtukan girma, da wasu cututtukan zuciya da jijiyoyin jini da na rayuwa.
- Kudin shiga: $22 Billion
- ROE: 14%
- Bashi/Adalci: 0.5
- Ma'aikata: 58k
Kiwon lafiya yana aiki a cikin ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon amfani da ikon mallakar kamfani guda huɗu: Neurology da Immunology, Oncology, Fertility, da General Medicine & Endocrinology. Matsayin bututun R&D na Kamfanin tare da bayyanannun mayar da hankali kan zama ƙwararrun ƙwararrun ƙwararrun duniya a cikin oncology, immuno-oncology, Neurology, da immunology.
3. Dermapharm
Dermapharm masana'anta ne mai saurin girma na samfuran magunguna. Kamfanin, wanda aka kafa a cikin 1991, yana cikin Grünwald kusa da Munich. Haɗin gwiwar tsarin kasuwanci na kamfanin ya haɗa da haɓaka cikin gida da samarwa da kuma siyar da samfura masu ƙima ta hanyar ƙwararrun masu siyar da magunguna.
- Kudin shiga: $1 Billion
- ROE: 45%
- Bashi/Adalci: 1.4
Baya ga babban wuri a Brehna kusa da Leipzig, Dermapharm yana aiki da sauran samarwa, haɓakawa da wuraren tallace-tallace a cikin Turai, musamman a cikin Jamus da Amurka.
Dermapharm yana siyar da amincewar magunguna sama da 1,300 tare da kayan aikin magunguna sama da 380 a cikin sashin “Magungunan Alama da Sauran Kayayyakin Lafiya”. Matsakaicin magunguna, samfuran likitanci da abubuwan abinci sun ƙware a cikin zaɓaɓɓun wuraren warkewa waɗanda Dermapharm ke kan gaba a matsayin kasuwa, musamman a Jamus.
4. Evotec
Evotec ya kafa kansa a matsayin kamfani na dandamali na duniya, yana ba da damar dandamalin multimodality da ke sarrafa bayanai don masu mallakar mallaka da kuma bincike na haɗin gwiwa, da kuma amfani da keɓaɓɓen haɗin fasahar sabbin fasahohi don ganowa da haɓaka na farko-a-aji da mafi kyawun-in- aji magunguna kayayyakin.
Cibiyar sadarwar ta abokan hulɗa ta haɗa da duk Top 20 Pharma da daruruwan kamfanonin fasahar kere-kere, cibiyoyin ilimi, da sauran masu ruwa da tsaki na kiwon lafiya. Evotec yana da ayyuka masu mahimmanci a cikin kewayon wuraren da ba a iya amfani da su a halin yanzu, ciki har da ilimin jijiya, ilimin cututtuka, da cututtuka na rayuwa da cututtuka.
- Kudin shiga: $0.62 Billion
- ROE: 34%
- Bashi/Adalci: 0.5
- Ma'aikata: 4k
A cikin waɗannan fannonin gwaninta, Evotec yana da niyyar ƙirƙirar bututun haɗin gwiwar mallakar duniya don sabbin hanyoyin warkewa da sanya su isa ga marasa lafiya a duk duniya. A yau, Kamfanin ya kafa fayil na fiye da 200 na mallakar mallaka da ayyukan R&D na haɗin gwiwa tun daga farkon ganowa zuwa haɓaka asibiti.
Evotec yana aiki a duniya tare da ƙwararrun mutane sama da 4,000 a shafuka 14 a cikin ƙasashe shida na Turai da Amurka. Shafukan Kamfanin a Hamburg (HQ), Cologne, Goettingen, da Munich (Jamus), Lyon da Toulouse (FaransaAbingdon da Alderley Park (Birtaniya), Verona (Italiya), Orth (Austria), da kuma a Branford, Princeton, Seattle da Watertown (Amurka) suna ba da fasaha da sabis na haɗin gwiwa sosai kuma suna aiki azaman ƙungiyoyi masu kyau.
5. Biotest
Biotest shine mai samar da samfuran furotin na plasma da magungunan biotherapeutic. Ana amfani da samfuran biotest da farko a cikin ilimin rigakafi na asibiti, ilimin jini da kuma maganin kulawa mai zurfi. Ana amfani da su don kula da mutane masu tsanani kuma galibi masu fama da cututtuka ta hanyar da aka yi niyya ta yadda yawanci za su iya yin rayuwa ta al'ada.
- Kudin shiga: $0.6 Billion
- ROE: -7%
- Bashi/Adalci: 1.2
- Ma'aikata: 2k
Biotest kwararre ne a cikin sabbin ilimin ilimin halittar jini, rigakafi na asibiti da kuma magani mai zurfi. Biotest yana haɓaka, samarwa da siyar da sunadaran plasma da magungunan biotherapeutic. Sarkar darajar ta haɗa da ci gaban asibiti da asibiti ta hanyar tallan duniya. Biotest yana samar da immunoglobulins, abubuwan coagulation da albumin bisa tushen jinin ɗan adam, waɗanda ake amfani da su a cikin cututtukan da ke cikin tsarin rigakafi ko tsarin samar da jini. Biotest yana ɗaukar mutane sama da 1,900 a duk duniya.
Mafi mahimmancin kayan da ake amfani da su na magunguna shine plasma na jini na ɗan adam, wanda muke sarrafa shi zuwa magunguna masu inganci kuma masu tsafta a ɗaya daga cikin wuraren zamani a Turai. Ana amfani da su wajen maganin cututtukan da ke barazana ga rayuwa irin su rikice-rikicen jini na jini (haemophilia), cututtuka masu tsanani ko rashin lafiya na tsarin rigakafi.
Gidan samar da Biotest yana cikin Dreieich, Jamus, a hedkwatar kamfanin. Tare da abokan aikin kwangila, Biotest yana aiwatar da har zuwa lita miliyan 1.5 na jini a kowace shekara.
A halin yanzu ana siyar da samfuran Biotest a cikin ƙasashe sama da 90 a duniya. Biotest yana tallata samfuran ta hanyar kamfanoninsa ko tare da haɗin gwiwar abokan kasuwancin gida ko masu rarrabawa.
